Reproductive Health Matters
Volume 8, Issue 15 , Pages 87-92 , May 2000

Preventing mother-to-child transmission of HIV in developing countries: Recent developments and ethnical implications

  • Catherine Hankins

      Affiliations

    • Corresponding Author InformationCorrespondence Catherine Hankins, Direction de la Santé Publique de Montreal. Centre and Joint Departments of Epidemiology, Biostatistics and Occupational Health, McGill University, 1301 rue Sherbrooke est, Montréal H2L 1M3, Canada.

References 

  1. UNAIDS Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 1999.
  2. World Health Organisation  . Recommendations on the safe and effective use of short-course ZDV for prevention of motherto-child transmission of HIV . Weekly Epidemiological Record . 1998;41:313–320 Geneva
  3. Cartoux M , Meda N , Van de Perre P , et al.  Ghent International Working Group on Mother-to-Child Transmission of HIV   Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey . AIDS . 1998;12:2489–2493
  4. Connor EM , Sperling RS , Gelber R , et al.   Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment . New England Journal of Medicine . 1994;331:1173–1180
  5. Wiktor SZ , Ekpini E , Karon JM , et al.   Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte D'Ivoire: a randomised trial . Lancet . 1999;353:781–785
  6. Dabis F , Msellati P , Meda N , et al.  DITRAME Study Group   6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial . Lancet . 1999;353:786–792
  7. DITRAME ANRS 049 Study Group . 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children . Lancet . 1999;353:2050–2051
  8. Shaffer N , Chuachoowong R , Mock P , et al.  Bangkok Collaborative Perinatal HIV Transmission Study Group   Lancet . 1999;353:773–780
  9. Guay LA , Musoke P , Fleming T , et al.   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial . Lancet . 1999;354:795–802
  10. Mofenson LM . Short-course zidovudine for prevention of perinatal infection . Lancet . 1999;354:766–767
  11. Aka-Dago-Akribi HA , Desgrées du Loû A , Msellati P , et al.   Issues surrounding reproductive choices for women living with HIV in Abidjan, Côte d'Ivoire . Reproductive Health Matters . 1999;7:20–29
  12. Canadian HIV/AIDS Legal Network  . Rapid HIV Screening at the Point of Care: Legal and Ethical Questions . 2000; Montreal, Canada www.aidslaw.ca
  13. Marseille E , Kahn JG , Mmiro F , et al.   Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa . Lancet . 1999;354:803–809
  14. Musoke P , Guay LA , Bagenda D , et al.   A phase I/II study of the safety and pharmacokinetics of neviparine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006) . AIDS . 1999;13(4):479–486
  15. Havlir DV , Eastman S , Gamst A , Richman D . Nevirapineresistant human immunodeficiency virus kinetics of replication and estimated prevalence in untreated patients . Journal of Virology . 1996;70:7894–7899
  16. Becker-Pergola G , Guay L , Mmiro F , et al.   Selection of the K103N nevirapine resistance mutation in Ugandan women receiving NVP prophylaxis to prevent HIV-1 Vertical transmision (HIVNET-006) . In: 7th Conference on Retroviruses and Opportunistic Infections . San Francisco, 30 Jan–2 Feb . 2000;
  17. World Health Organization  . Use of nevirapine to reduce motherto-child transmission of HIV (MCTCT) . WHO Review of Reported Drug Resistance . 24 March 2000; Geneva, www.who.int/reproductivehealth/publications/ nevirapine/report.htm
  18. Hirsch MS , Conway B , D'Aquila RT , et al. , International AIDS Society-USA Panel    Antiretroviral drug resistance testing in adults with HIV infection. Implications for clinical management . JAMA . 1998;279:1984–1991
  19. Giles RE , Perry KR , Parry JV . Simple/rapid test devices for anti-HIV screening: do they come up to the mark? . Journal of Medical Virology . 1999;59:104–109
  20. Downing RG , Otten RA , Marum E , et al.   Optimizing the delivery of HIV counselling and testing services: the Uganda experience using rapid HIVA antibody test algorithms . Journal of Acquired Immune Deficiency Syndrome & Human Retrovirol . 1998;18:384–388
  21. BBC News Online. January 2000. http://news,bbc.co.uk/hi/ english/world
  22. Gannon JC. The global infectious disease threat and its implications for the USA. www.cia.gov/cia/publications/ nie/report/nie99-17d.html
  23. Berer M . Reducing perinatal HIV transmission in developing countries in the context of antenatal and delivery care and breastfeeding: Supporting infant survival by supporting women's survival . Bulletin of WHO . 1999;77(11):871–877

PII: S0968-8080(00)90009-0

Reproductive Health Matters
Volume 8, Issue 15 , Pages 87-92 , May 2000

Article Tools